Watch out Alnylam/Ionis: Pfizer’s positive PhIII tafamidis data makes drug a new rival
Pfizer $PFE reported out some good news from a late-stage trial testing its drug tafamidis against a rare condition that leads to heart failure. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.